Strategies for treatment with anti-tumor necrosis factor agents in psoriasis: maintaining efficacy and safety for the long haul.
Gordon
Kenneth B
KB
Gandhi
Mona
M
D006801:Humans; D007155:Immunologic Factors / Q000276:immunology / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha